Related Experiment Videos

[Fundamental and clinical studies on ceftazidime in neonates and premature infants]

Insights

Ceftazidime (CAZ) pharmacokinetics in neonates showed dose-dependent plasma concentrations and shorter half-lives in older infants. Urinary recovery rates were consistent across age groups, indicating predictable elimination.

Area of Science:

  • Pharmacology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Bacterial infections pose significant risks to neonates.
  • Ceftazidime (CAZ) is a third-generation cephalosporin antibiotic used for treating bacterial infections.

Related Concept Videos